CP-037 Use of sofosbuvir in hepatitis C
BackgroundHepatitis C is a serious disease with a high prevalence, being the leading cause of liver transplantation. There is now rapid development of new drugs for this disease. During the period of this study, only the following anti-hepatitis C agents were available: peg-interferon, telaprevir, b...
Gespeichert in:
Veröffentlicht in: | European journal of hospital pharmacy. Science and practice 2016-03, Vol.23 (Suppl 1), p.A16-A16 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!